PTP1B plays a pivotal role in the regulation of insulin and leptin, and is a target for diabetes therapies; small-molecule inhibitors of PTP1B have been developed which could have potential application to cancer therapy. The gene discussed is PTPN1; the disease is diabetes mellitus.